Cargando…
The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis
The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practic...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866890/ https://www.ncbi.nlm.nih.gov/pubmed/29713640 http://dx.doi.org/10.1155/2018/1868254 |
_version_ | 1783308892220948480 |
---|---|
author | Gasparini, Giulio Saponaro, Gianmarco Gasparini, Daniela Foresta, Enrico Azzuni, Camillo Adduci, Alessia Boniello, Roberto Moro, Alessandro De Angelis, Paolo Di Nardo, Francesco Damato, Giuseppe Doneddu, Piero Todaro, Mattia Garagiola, Umberto Pelo, Sando |
author_facet | Gasparini, Giulio Saponaro, Gianmarco Gasparini, Daniela Foresta, Enrico Azzuni, Camillo Adduci, Alessia Boniello, Roberto Moro, Alessandro De Angelis, Paolo Di Nardo, Francesco Damato, Giuseppe Doneddu, Piero Todaro, Mattia Garagiola, Umberto Pelo, Sando |
author_sort | Gasparini, Giulio |
collection | PubMed |
description | The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives. |
format | Online Article Text |
id | pubmed-5866890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-58668902018-04-30 The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis Gasparini, Giulio Saponaro, Gianmarco Gasparini, Daniela Foresta, Enrico Azzuni, Camillo Adduci, Alessia Boniello, Roberto Moro, Alessandro De Angelis, Paolo Di Nardo, Francesco Damato, Giuseppe Doneddu, Piero Todaro, Mattia Garagiola, Umberto Pelo, Sando Biomed Res Int Clinical Study The use of anaesthetic drugs in the treatment of oral aphthosis is one of the pharmaceutical possibilities that a doctor can use for the most painful forms. Normally, Lidocaine or Diclofenac is used to treat this disease, but they can be used for a very limited time and so they are of little practical use. In this study, the authors have used Ropivacaine whose pharmaceutical kinetics allows the analgesic effect to be active for 60 to 90 minutes. In our research, we compared 8 groups of patients who have been given 3 principal pharmaceutical products: one group was given an anaesthetic drug, one had a topical medication administered which is often used for the treatment of aphthous lesions, and the last group was given a multivitamin. These pharmaceutical products were used alone and in various possible combinations in the 8 groups. The results of this study are very interesting and show that in all the groups that used anaesthetics there was more satisfaction on the patients' part because their pain level became more manageable right after the first application of the drug and the patients could carry on with their normal lives. Hindawi 2018-03-11 /pmc/articles/PMC5866890/ /pubmed/29713640 http://dx.doi.org/10.1155/2018/1868254 Text en Copyright © 2018 Giulio Gasparini et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Gasparini, Giulio Saponaro, Gianmarco Gasparini, Daniela Foresta, Enrico Azzuni, Camillo Adduci, Alessia Boniello, Roberto Moro, Alessandro De Angelis, Paolo Di Nardo, Francesco Damato, Giuseppe Doneddu, Piero Todaro, Mattia Garagiola, Umberto Pelo, Sando The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title | The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title_full | The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title_fullStr | The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title_full_unstemmed | The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title_short | The Use of Ropivacaine in Therapeutic Treatment of Oral Aphthosis |
title_sort | use of ropivacaine in therapeutic treatment of oral aphthosis |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866890/ https://www.ncbi.nlm.nih.gov/pubmed/29713640 http://dx.doi.org/10.1155/2018/1868254 |
work_keys_str_mv | AT gasparinigiulio theuseofropivacaineintherapeutictreatmentoforalaphthosis AT saponarogianmarco theuseofropivacaineintherapeutictreatmentoforalaphthosis AT gasparinidaniela theuseofropivacaineintherapeutictreatmentoforalaphthosis AT forestaenrico theuseofropivacaineintherapeutictreatmentoforalaphthosis AT azzunicamillo theuseofropivacaineintherapeutictreatmentoforalaphthosis AT adducialessia theuseofropivacaineintherapeutictreatmentoforalaphthosis AT bonielloroberto theuseofropivacaineintherapeutictreatmentoforalaphthosis AT moroalessandro theuseofropivacaineintherapeutictreatmentoforalaphthosis AT deangelispaolo theuseofropivacaineintherapeutictreatmentoforalaphthosis AT dinardofrancesco theuseofropivacaineintherapeutictreatmentoforalaphthosis AT damatogiuseppe theuseofropivacaineintherapeutictreatmentoforalaphthosis AT doneddupiero theuseofropivacaineintherapeutictreatmentoforalaphthosis AT todaromattia theuseofropivacaineintherapeutictreatmentoforalaphthosis AT garagiolaumberto theuseofropivacaineintherapeutictreatmentoforalaphthosis AT pelosando theuseofropivacaineintherapeutictreatmentoforalaphthosis AT gasparinigiulio useofropivacaineintherapeutictreatmentoforalaphthosis AT saponarogianmarco useofropivacaineintherapeutictreatmentoforalaphthosis AT gasparinidaniela useofropivacaineintherapeutictreatmentoforalaphthosis AT forestaenrico useofropivacaineintherapeutictreatmentoforalaphthosis AT azzunicamillo useofropivacaineintherapeutictreatmentoforalaphthosis AT adducialessia useofropivacaineintherapeutictreatmentoforalaphthosis AT bonielloroberto useofropivacaineintherapeutictreatmentoforalaphthosis AT moroalessandro useofropivacaineintherapeutictreatmentoforalaphthosis AT deangelispaolo useofropivacaineintherapeutictreatmentoforalaphthosis AT dinardofrancesco useofropivacaineintherapeutictreatmentoforalaphthosis AT damatogiuseppe useofropivacaineintherapeutictreatmentoforalaphthosis AT doneddupiero useofropivacaineintherapeutictreatmentoforalaphthosis AT todaromattia useofropivacaineintherapeutictreatmentoforalaphthosis AT garagiolaumberto useofropivacaineintherapeutictreatmentoforalaphthosis AT pelosando useofropivacaineintherapeutictreatmentoforalaphthosis |